Nick Dand

Clinical and genetic differences between pustular psoriasis subtypes

Sophie Twelves, Alshimaa Mostafa, Nick Dand et al. · Journal of Allergy and Clinical Immunology · 2018 · 259 citations · Full text

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Nick Dand, Michael Duckworth, David Baudry et al. · Journal of Allergy and Clinical Immunology · 2018 · 162 citations · Full text

Autoimmune Disease, Medicine, Biologic Treatment Response +9

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic target

Satveer K. Mahil, Marika Catapano, Paola Di Meglio et al. · Science Translational Medicine · 2017 · 146 citations · Full text

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, <scp>BADBIR</scp> )

Satveer K. Mahil, Nina Wilson, Nick Dand et al. · British Journal of Dermatology · 2019 · 143 citations · Full text